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Three-dimensional electron 
microscopy reveals the evolution of 
glomerular barrier injury
Michael J. Randles1,2,*, Sophie Collinson1,*, Tobias Starborg1,3, Aleksandr Mironov3, 
Mira Krendel4, Eva Königshausen5, Lorenz Sellin5, Ian S. D. Roberts6, Karl E. Kadler1, 
Jeffrey H. Miner7 & Rachel Lennon1,2
Glomeruli are highly sophisticated filters and glomerular disease is the leading cause of kidney 
failure. Morphological change in glomerular podocytes and the underlying basement membrane are 
frequently observed in disease, irrespective of the underlying molecular etiology. Standard electron 
microscopy techniques have enabled the identification and classification of glomerular diseases based 
on two-dimensional information, however complex three-dimensional ultrastructural relationships 
between cells and their extracellular matrix cannot be easily resolved with this approach. We employed 
serial block face-scanning electron microscopy to investigate Alport syndrome, the commonest 
monogenic glomerular disease, and compared findings to other genetic mouse models of glomerular 
disease (Myo1e−/−, Ptpro−/−). These analyses revealed the evolution of basement membrane and 
cellular defects through the progression of glomerular injury. Specifically we identified sub-podocyte 
expansions of the basement membrane with both cellular and matrix gene defects and found a 
corresponding reduction in podocyte foot process number. Furthermore, we discovered novel podocyte 
protrusions invading into the glomerular basement membrane in disease and these occurred frequently 
in expanded regions of basement membrane. These findings provide new insights into mechanisms of 
glomerular barrier dysfunction and suggest that common cell-matrix-adhesion pathways are involved in 
the progression of disease regardless of the primary insult.
Glomerular disease is characterised by persistent proteinuria, with or without haematuria, and a progressive 
decline in renal function. Currently, no curative therapy exists and patients are reliant upon non-specific treat-
ments. Glomerular dysfunction can result from genetic defects, inflammatory insults or can be secondary to sys-
temic disease such as diabetes mellitus. Alport syndrome is the commonest monogenic glomerular disease and is 
characterised by progressive glomerular dysfunction, sensorineural deafness and ocular abnormalities1. Patients 
with Alport syndrome are treated with renin-angiotensin-aldosterone system (RAAS) inhibitors and this therapy 
has been shown to prolong renal function by over 15 years2. However, many patients ultimately progress to end 
stage renal disease and more effective therapies are urgently needed.
The molecular origin of Alport Syndrome was first described in 1990 when mutations in COL4A5 were 
reported3. COL4A5 is expressed on the X-chromosome and therefore hemizygous males are more severely 
affected than heterozygous females3,4. Subsequently, mutations in COL4A3 and COL4A4 were discovered and 
in this scenario two mutated alleles cause autosomal recessive disease5–7. Within the kidney, glomerular podo-
cytes are the only cells known to express COL4A3, COL4A4 and COL4A58, and these genes are required for the 
assembly of the type IV collagen α 3α 4α 5 network in the glomerular basement membrane (GBM). The GBM is 
a complex niche of extracellular matrix (ECM) proteins that is essential for normal glomerular function9. In the 
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adult glomerulus the GBM is composed of predominately type IV collagen α 3α 4α 5, laminin α 5β 2γ 1 and up to 70 
additional structural and regulatory components10. Evidence suggests that type IV collagen α 3α 4α 5 is important 
for the lifelong structural integrity of the GBM11, as the type IV collagen α 1α 1α 2 network, produced by both 
podocytes and glomerular endothelial cells12, is unable to compensate for the absence of the α 3α 4α 5 network in 
Alport Syndrome13,14.
Renal biopsy is a valuable diagnostic tool for defining the sub-type of glomerular disease; indeed a diagnostic 
marker for Alport Syndrome is the pathological basket weave appearance of the GBM, although genetic test-
ing is now superseding biopsy15. Other histopathological features of glomerular disease include altered GBM 
thickness, loss of unique podocyte structures called foot processes (FPs) and a reduction in podocyte number16. 
Interestingly, these features are reported across the spectrum of glomerular disease regardless of the underlying 
molecular aetiology. Yet the mechanisms underpinning these morphological changes are poorly understood. In 
particular we have not defined the ultrastructural relationship between podocytes and the GBM during the pro-
gression of glomerular disease, however this knowledge could provide insight into disease mechanisms.
To address this knowledge gap we employed serial block face-scanning electron microscopy (SBF-SEM) to 
examine the relationships of cells and ECM in three-dimensions (3D). This approach was recently used to inves-
tigate cell-ECM interactions17–20 and the complexities of normal podocyte structure21. However, until now, the 
approach has not been used to investigate changes in podocytes and the GBM during disease progression. We 
hypothesized that SBF-SEM over a time course would enable the construction of detailed 3D models of the glo-
merulus in health and disease and would reveal novel pathological features.
Results
3D modelling of glomerular structure in Alport nephropathy.  Over a 28-week time course we inves-
tigated Col4a3−/− male mice on a C57BL/6J genetic background. We selected this background, which has a 
slow progression of glomerular disease, to allow a greater window of observation. We analyzed glomeruli using 
SBF-SEM and created 3D glomerular reconstructions (Supplementary Movie S1). The glomerulus is composed of 
interwoven capillary loops forming a complex pattern of lumens when viewed in 3D. The localization of the GBM, 
podocyte cell bodies and foot processes (FPs) can be easily discerned using SBF-SEM (Fig. 1a). From wild type 
16–18 week (older adult) mouse glomeruli we generated models of podocytes and GBM and these revealed an 
organized glomerular structure (Fig. 1a,b). We compared these models with glomeruli from 6-week (young adult) 
Col4a3+ /− and Col4a3−/− animals and found that the majority of podocytes had regular FPs (Fig. 2). This 
finding was also observed in older adult Col4a3−/− mice although some FPs were flattened or effaced (Fig. 2). 
In contrast, 28-week (aged) Col4a3−/− mice had striking global loss of podocyte FP organization, GBM thick-
ening and thinning (Fig. 2). Further analysis revealed focal regions of reduced podocyte FP density in all groups 
of Col4a3−/− mice, even in young adult mice, when compared with age matched wild type and Col4a3+ /−  
mice (Fig. 3a,b). These areas were often concomitant with thickened, non-uniform sheets of GBM (Fig. 3a,c and 
Supplementary Movies S2 and S3). Moreover, the density of podocyte FPs decreased with age in Col4a3−/− mice 
(Fig. 3b) and correlated with increased thickness and variation in thickness of the GBM (Fig. 3c).
Podocytes invade into the GBM in Alport nephropathy. The appearance of cellular material within 
the GBM has been previously described. Erythrocytes have occasionally been captured traversing the GBM in 
thin basement membrane nephropathy22. Podocyte infolding in the GBM has also been described in a range of 
glomerular pathologies23 and more recent investigation of Col4a3−/− mice, suggested that cellular interposition 
in the GBM is of mesangial cell origin24. Mesangial cells are located between adjacent capillary loops and have 
contact with the GBM at the bases of the capillary loops (Supplementary Fig. S1a). In contrast, podocytes directly 
adhere to the GBM of the capillary walls (Fig. 1a,b). Using SBF-SEM we were able to identify cellular invasions 
within the GBM that connected to podocyte FPs (Fig. 4a,b and Supplementary Movies S4 and S5). These inva-
sions were rarely observed in young adult Col4a3−/− mice (Fig. 5a) and were never observed in Col4a3+ /−  
or wild type mice. In contrast, older adult and aged Col4a3−/− mice had frequent podocyte invasions (Figs 4c 
and 5b–d). The lengths of podocyte invasions were variable, but the mean length increased with age (Fig. 5e). 
Moreover, they occurred more frequently in thickened and abnormal areas of GBM in Col4a3−/− mice (Figs 4c 
and 5f). In aged Col4a3−/− mice the entire GBM had irregular thickness and all regions of the GBM contained 
podocyte invasions (Fig. 5d,f). Since it is known that the genetic background of Alport mice has an effect on the 
rate of disease progression25, we also investigated Col4a3−/− mice on a 129S1/Svlmj background with SBF-SEM. 
Here, similarly, we found evidence of podocytes invading into the GBM (Supplementary Fig. S2a–e).
Podocyte-GBM invasion is a common feature in glomerular disease. To investigate whether podo-
cyte invasion into the GBM is a unique feature of Alport Syndrome, or shared with other genetic glomerular 
diseases, we investigated two additional mouse models of human disease. MYO1E mutations in humans cause 
steroid resistant focal segmental glomerulosclerosis (FSGS)26. MYO1E encodes myosin1e, a class I myosin which 
is expressed by mouse and human podocytes26,27. Myo1e−/− mice develop FSGS and renal failure associated 
with morphological abnormalities in both podocytes and the GBM; we therefore investigated adult Myo1e−/− 
mouse glomeruli with SBF-SEM. Our analysis revealed that podocyte FPs were flattened, broadened and in many 
regions completely effaced (Fig. 6a–c). There were expanded areas of GBM that coincided with loss of podocyte 
FP morphology (Fig. 6d). Overall, there was a loss of podocyte FP density and a thickening of the GBM (Fig. 6f,g). 
Along with these classical pathological changes in podocyte and GBM ultrastructure, we also discovered preva-
lent podocyte FP invasion into the GBM (Fig. 7a, Supplementary Fig. S3a and Supplementary Movie S6).
Next we investigated a third mouse model of human glomerular disease. Glomerular epithelial protein 1 
(GLEPP1) is a receptor tyrosine phosphatase expressed by podocytes. Mutations in PTPRO the gene that encodes 
GLEPP1 protein causes childhood-onset nephrotic syndrome in humans28. Ptpro−/− mice have impaired renal 
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Figure 1. The 3D morphology of podocyte foot processes and the GBM. 3D reconstructions from SBF-SEM 
images of wild type glomerulus from an 18-week C57Bl/6 mouse. (a) A single slice from an SBF-SEM stack 
showing a glomerulus in cross section. Glomerular capillary lumens are highlighted in red, the GBM in blue and 
podocyte cell bodies in green. Regions of interest (ROIs) show that podocyte FPs from two adjacent podocytes 
(one green the other magenta) can clearly be discerned using this technique. (b) Panel displays a transverse view 
of reconstructed podocyte FPs and GBM. Removing slices (increasing Z distance) reveals the 3-dimensional 
organization of the foot processes. Serial block face-scanning electron microscopy, SBF-SEM; glomerular 
basement membrane, GBM; foot processes, FPs.
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function and SEM has demonstrated that these mice have shortened podocyte FPs29. We investigated adult 
Ptpro−/− mice with SBF-SEM and found dramatic GBM expansions, overall GBM thickening and focal areas 
of reduced podocyte FP density (Fig. 6a–d,f,g). Furthermore we identified podocyte invasions into the GBM 
Figure 2. Normal podocyte FP and GBM structure is lost with age in Alport mice. Transverse views of 
reconstructed GBMs (blue) and podocyte FPs (green and magenta) from wild type, Col4a3−/− mice and 
Col4a3−/− mice. Many regions in young adult (young) and older adult (adult) Col4a3−/− mice display 
organized podocyte FPs and uniform GBM of thickness comparable to wild type adult animals. GBM, 
glomerular basement membrane; FPs, foot processes.
www.nature.com/scientificreports/
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similar to those observed in Col4a3−/− mice and Myo1e−/− mice (Supplementary Movie S7). In contrast to 
Col4a3−/− and Myo1e mice, podocyte invasions into the GBM in Ptpro−/− mice were more slender and short 
(Fig. 7b and Supplementary Fig. S3b). In addition, podocyte invasions in Ptpro−/− mice were less variable in 
length than those in adult and aged Col4a3−/− mice (Fig. 7c). Similar to Col4a3−/− mice, podocyte invasions 
were associated with thickened regions of GBM in both Myo1e−/− and Ptpro−/− mice (Fig. 7d).
Mesangial cells invade the GBM at the mesangial aspect. Using 3D modelling of glomerular struc-
ture we also analysed the mesangial cells since they have been reported to invade the GBM in Alport syndrome24. 
Indeed, analysing SBF-SEM from Alport mice we identified mesangial invasions of varying length inside the 
GBM along the mesangial aspect of the glomerular capillary loop (Supplementary Fig. S1b and Supplementary 
Movies S9 and S10). These mesangial processes were distinct from podocyte invasions; they were only observed 
close to the mesangial angle and not in the peripheral capillary loops. We also detected mesangial invasions 
in both Myo1e−/− and Ptpro−/− mice (Supplementary Fig. S1c,d and Supplementary Movies S10 and S11). 
Mesangial invasions were rarer than podocyte invasions and in contrast to podocyte invasions, mesangial inva-
sions were also present in wild type animals (Supplementary Movie S8). However, mesangial invasions were 
longer in mice with Col4a3, Myo1e and Ptpro mutations compared with wild type mice (Fig. S1E, Movie S9–11).
GBM defects resembling podocyte invasion in human Alport syndrome. We interrogated TEM 
sections from the renal biopsies of two siblings that we have previously reported30. The proband was investigated 
for persistent microscopic haematuria and mild proteinuria and he had a renal biopsy at 3 years of age. This 
demonstrated abnormal GBM thickness, which prompted COL4 genetic screening. He was found to be hem-
izygous for two COL4A5 variants: c.2858G > T; p.(Gly953Val) and c.3097G > C; p.(Gly1033 Arg). His younger 
brother presented at the age of 6 months with steroid resistant nephrotic syndrome and was also hemizygous for 
the same COL4A5 variants. In addition he carried two homozygous missense variants in MYO1E: c.352A > G; 
p.(Lys118Glu) and c.2627C > G; p.(Thr876Arg). In both renal biopsies there was evidence of electron lucent 
regions within the GBM (Fig. 8). In addition, there was evidence of cellular material within the GBM and these 
resembled the podocyte invasions that we observed in Col4a3−/−, Myo1e−/− and Ptpro−/− mice. Future 
SBF-SEM studies of human biopsies are needed to confirm that the cellular material is indeed podocyte protru-
sions as we have shown in the mouse.
Figure 3. 3D analysis of glomerular structure in aging Col4a3−/− mice. (a) Transverse view of 
reconstructed GBMs (blue) and podocyte FPs (green and magenta) reveal focal areas of podocyte FP effacement 
that coincide with thickened irregular regions of GBM. (b) Quantification of podocyte FP density. The violin 
plots demonstrate the distributions for the number of FPs per length of GBM along the y-axis, the black lines 
represent the mean number of FPs per length of GBM in each group. (C) Quantification of GBM thickness. 
The violin plots describe the distributions for the thickness of GBM along the y-axis, the black lines represent 
the mean thickness of the GBM in each group. GBM, glomerular basement membrane; FPs, foot processes; 
*P < 0.05; ****P < 0.0001.
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6Scientific RepoRts | 6:35068 | DOI: 10.1038/srep35068
Discussion
In this study we used SBF-SEM to analyze spatial relationships between cellular and extracellular glomerular com-
ponents in health and disease. We identified podocyte invasions into the GBM as a novel morphological feature 
of glomerular disease. Irregular expansions of the urinary surface of the GBM were also a dominant feature in all 
disease models and these irregular expansions were more likely to harbor podocyte invasions. Podocyte invasions 
occurred in Alport (Col4a3−/−), Myo1e−/− and Ptpro−/− mice and lucent regions of GBM, resembling sites of 
podocyte invasion, were seen in patients with Alport syndrome. Finally, we demonstrate that GBM thickness and 
irregularity markedly increases and podocyte FP density decreases with glomerular disease progression.
Figure 4. Identification of podocyte FPs invading the GBM in Alport syndrome. (a) Tracking of cellular 
material embedded within the GBM through 50 nm sections revealed that this material originates from 
podocyte FPs. (b) Tilted view of the model generated in A. showing the interaction of the invading FP with 
the BM. (c) Distribution of GBM invasions of podocyte origin (magenta) recorded in 10,000 μ m3 glomerular 
volume. Podocyte FP invasions were not present in wild type adult or Col4a3+ /− mice, they were rarely 
observed in young Col4a3−/mice, but were abundant in adult and aged Col4a3−/− mice. GBM, glomerular 
basement membrane.
www.nature.com/scientificreports/
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Figure 5. Analysis of podocyte FP invasions in Alport mice. (a) Reconstructed podocyte GBM interface in 
a young adult (6 week) Col4a3−/− mouse. Podocyte cell body (green) and FPs from a neighbouring podocyte 
(magenta) are shown. A rare example of two short podocyte FP invasions inside the GBM (blue) is shown 
in young Col4a3−/− mice (right hand panel). The GBM in this region in thickened relative to the rest of the 
GBM. (b) SBF-SEM reconstruction reveals two FPs invading an abnormally thickened area of GBM in an adult 
(16 week) Col4a3−/− mouse. (c) The number of FP invasions increase with age in Col4a3−/− mice. (d) FP 
invasions are frequent in aged (28 week) Col4a3−/− mice. The GBM is irregular in thickness, both thinned 
and thickened compared to young GBM. (e) Quantification of podocyte FP invasions. The violin plots describe 
the distributions for the length of podocyte invasion into the GBM along the y-axis, the black lines represent 
the mean length of podocyte GBM invasions in each group. (f) Quantification of GBM thickness at sites of 
podocyte invasion. The violin plots describe the distributions for the thickness of GBM at sites of podocyte 
invasion and sites where there is no podocyte invasion. The black lines represent the mean GBM thickness of 
each group. GBM, glomerular basement membrane; FPs, foot processes; *P < 0.05; ****P < 0.0001.
www.nature.com/scientificreports/
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The GBM is a critical component of the glomerular filtration barrier being exquisitely water permeable yet 
prohibiting the passage of macromolecules. Super resolution microscopy was recently used to describe the precise 
molecular topology of the GBM31. In this nanoscale investigation of the GBM, type IV collagen was shown to be 
Figure 6. 3D analysis of Myo1e−/− and Ptpro−/− mouse glomerular structure. (a) Transverse view of 
reconstructed GBMs (blue) and podocyte FPs (green and magenta) reveal broadened and flattened FPs in 
Myo1e−/− and Ptpro−/− mice. (b) Large expansions of GBM occur in Myo1e−/− and Ptpro−/− mice.  
(c) Focal areas of podocyte FP effacement coincide with thickened and irregular regions of GBM in Myo1e−/− 
and Ptpro−/− mice. (d) In many regions there is complete effacement of podocyte FPs in in Myo1e−/− and 
Ptpro−/− mice. (e) Quantification of podocyte FP density. The violin plots describe the distributions for the 
number of FPs per length of GBM along the y-axis, the black lines represent the mean number of FPs per length 
of GBM in each group. (f) Quantification of GBM thickness. The violin plots describe the distributions for the 
thickness of GBM along the y-axis, the black lines represent the mean thickness of the GBM in each group. 
GBM, glomerular basement membrane; FPs, foot processes; ****P < 0.0001.
www.nature.com/scientificreports/
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restricted to the centre of the GBM. This localization indicates that the collagen IV network is too distant from 
podocytes to interact with integrins at the cell surface and therefore initiate outside-in signaling. This paper also 
demonstrated that type IV collagen α 1α 1α 2 mislocalizes during Alport syndrome and is found adjacent to podo-
cytes. Type IV collagen α 1α 1α 2 that is proximal to podocytes could conceivably perturb cell-ECM interactions 
or alter the organization of other components within the GBM. In our investigation, we identified novel podocyte 
protrusions into the GBM and one explanation for podocyte invasion is that increased GBM degradation and 
subsequent podocyte migration occur in order to improve podocyte anchorage and to prevent detachment. A 
second, attractive explanation is that podocytes use invasions to remodel GBM damage that is caused by altered 
filtration forces. Potentially, podocyte invasions are extensions of plasma membrane used to remodel ECM, simi-
lar to fibropositors that regulate the direction of collagen fibril assembly during tendon repair24.
Our investigation of human GBM was limited to TEM sections since archival EM blocks from human biop-
sies are not routinely stained with heavy metals prior to embedding. For SBF-SEM staining is required prior to 
embedding since sectioning is automated within the microscope. In the human TEM we observed lucent regions 
in the GBM, resembling the regions in the mouse GBM that were tracked to podocyte protrusions and we there-
fore propose that the same protrusions occur in human glomerular disease. These observations are likely to over-
lap with the previously reported podocyte infolding in the GBM, seen across a range of glomerular pathologies23.
Defining the molecular composition and nature of podocyte invasions into the GBM would determine 
whether these could be therapeutically blocked or activated in order to protect glomerular function. There are a 
number of candidate pathways that could drive podocyte invasion into the GBM. One such pathway is integrin 
mediated adhesion signalling. Focal adhesion kinase (FAK), a key integrin signalling protein, has been shown 
to be activated in Alport mouse podocytes by ectopic laminin α 232. This same study revealed that FAK induces 
matrix metalloproteinase (MMP) release from podocytes. This proposes an explanation for podocyte protrusion 
into the GBM following podocyte-mediated ECM degradation. Indeed TEM imaging provides evidence of an 
Figure 7. Podocyte-GBM invasion is a common feature in glomerular disease. (a) Reconstructed podocyte  
GBM invasion in Myo1e−/− mouse. Podocyte invasion (magenta) and GBM (blue) are shown. (b) Reconstructed 
podocyte GBM invasion in Ptpro−/− mouse. Podocyte invasion (green) and GBM (blue) are shown. (c) Quantification 
of podocyte FP invasions. The violin plots describe the distributions for the length of podocyte invasion into the 
GBM along the y-axis, the black lines represent the mean length of podocyte GBM invasions in each group.  
(d) Quantification of GBM thickness at sites of podocyte invasion. The violin plots describe the distributions for 
the thickness of GBM at sites of podocyte invasion and sites where there is no podocyte invasion. The black lines 
represent the mean GBM thickness of each group. GBM, glomerular basement membrane; FPs, foot processes; 
****P < 0.0001.
www.nature.com/scientificreports/
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Figure 8. Evidence for podocyte invasion in patients with Alport syndrome. Transmission electron 
microscopy of an Alport patient with mutant COL4A5 alleles c.2858G > T; p.(Gly953Val) and c.3097G > C; 
p.(Gly1033 Arg) (a) and a sibling who in addition to carrying COL4A5 variants had mutations in MYO1E: 
c.352A > G; p.(Lys118Glu) and c.2627C > G; p.(Thr876Arg) (b) These TEMs reveal features that resemble 
podocyte invasions identified in mouse models of glomerular disease.
www.nature.com/scientificreports/
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electro-lucent halo around FP invasions (Figure S4), which could be the result of active ECM degradation by 
podocytes.
In conclusion, SBF-SEM has provided enhanced visualization of the glomerulus and this has led to the iden-
tification of previously unseen pathological features of glomerular disease. 3D ultrastructural imaging revealed 
expected GBM abnormalities in addition to podocyte protrusions, resembling invadosomes, in the GBM. This 
novel finding provides new insight into disease mechanisms and suggests that a common matrix-adhesion path-
way is activated regardless of the primary molecular insult. What remains unknown is whether podocytes actively 
migrate into the GBM or if these protrusions occur passively. Further study is necessary to understand how and 
why podocytes protrude into the GBM. Answers to these questions could lead to the development of targeted 
therapies that would offer new therapeutic avenues for glomerular disease.
Methods
Mouse models. All animal experiments were performed in accordance with the relevant institutional 
approvals. The Col4a3−/− mice have been reported previously33 and experiments on these mice conformed to 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
Washington University Animal Studies Committee. For Myo1e−/− mice27 experiments were performed accord-
ing to the protocol approved by the SUNY Upstate Animal Committee. Ptpro−/− mice29 were backcrossed 
onto a 129P3/J background34 and the experiments were approved by Heinrich Heine University, Düsseldorf. 
C57BL/6JOIaHsd male mice were used as WT controls. A minimum of 3 animals per group were analysed in 
this study.
Serial block face-scanning electron microscopy. Kidney samples were prepared for SBF-SEM as 
described previously17. In brief, mouse kidneys were cut into 1 mm cubes and fixed in situ by using 2% (wt/vol) 
glutaraldehyde (Agar Scientific, UK) in 0.1 M cacodylate buffer (pH 7.2); stained in 1% (wt/vol) osmium tetrox-
ide, 1.5% (wt/vol) potassium ferrocyanide in 0.1 M cacodylate buffer, followed by 1% (wt/vol) thiocarbohydrazide. 
After washing, more osmium was added by staining in 1% (wt/vol) osmium tetroxide, and soaked in 1% (wt/vol) 
uranyl acetate overnight. The final staining step incubation was performed at 60 °C with lead aspartate pH 5.5 for 
one hour. Samples were dehydrated in ethanol and infiltrated in TAAB 812 hard resin. Tissue was mounted onto 
an aluminium cryo pin (Electron Microscopy Sciences, cat. no. 70446) using cyanoacrylate glue and all block 
surfaces trimmed at 90° using a glass knife or diamond trimming tool (Diatome). A gold coating was applied to 
the block to create a conductive surface. The block was placed in the Quanta 250 FEG (FEI Company) + Gatan 
3view system and a 41 μ m × 41 μ m field of view was chosen and imaged by using a 4096 × 4096 scan, which gave 
an approximate pixel size of 10 nm. The section thickness was set to 50 nm in the Z (cutting) direction.
Transmission electron microscopy and quantification.  Sample fixation and staining was performed 
as for SBF-SEM. Different blocks from the same sample were used for TEM and SBF-SEM. Tissue blocks were 
removed from their moulds and sectioned (70–80 nm thickness). Sections were examined using a FEI Tecnai 
12G2 Biotwin transmission electron microscope. Magnification varied from 145X to 6800X. n = 6 glomeruli were 
imaged for each mouse model. Images were saved as original.dm3 files and.tiff files. The dm3 files were opened 
using Fiji/ImageJ software version 2.0.0-rc-29/1.49r. Collectively 60 randomly selected points of the GBM across 
50.dm3 images were measured to assess GBM thickness. The straight-line option was used to draw across the 
width of the GBM at the chosen point > Analyse > Measure. To quantify podocyte FP number and FP protru-
sions 50 randomly selected areas of GBM 5 μ m in length were measured as above and FP or protrusion number 
counted manually. Where protrusions were identified the thickness of the infiltrated GBM was also measured. 
All measurements were imported into GraphPad Prism software version 5.0 for interpretation and graphical 
representation.
3D modeling.  Typically, Z volumes datasets comprised 1000 images (50 μ m z depth). The IMOD beta ver-
sion 4.7.11 suite of image analysis software was used to build image stacks, reduce imaging noise, and generate 
3D reconstructions35. A shell script was run to float images to a common density range, following which they 
were converted to a size 8 bit smoothed data MRC file as reported previously17. A 24″ Wacom tablet with inter-
active pen tool was used to construct 3D models from the MRC file open in IMOD. The image stack was scrolled 
through to locate a feature of interest e.g. the GBM. The pen tool was positioned over this feature and a contour 
drawn around the entire structure. The image stack was moved up or down by one section and a second contour 
was drawn around the same feature. This process was repeated on every image for the desired number of sections.
Statistical analysis. 170 measurements of podocyte FP density and 70 measurements of GBM thickness 
were taken per group. All identified invasions were quantified and invasion number was normalised to the total 
volume of glomerulus analysed. Comparisons between individual disease models and wild type were performed 
in GraphPad Prism using one way ANOVA with a Tukey’s post-test, p values less than 0.05 were considered to be 
significant.
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